Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Altimmune's peak revenue was $25.2M in 2012. The peak quarterly revenue was $5.0K in 2024(q4).
Altimmune's revenue increased from $21.0m in 2010 to $20.0K currently. That's a -99.9% change in annual revenue.
| Fiscal year / year | Altimmune revenue |
|---|---|
| 2010 | $21.0M |
| 2011 | $24.3M |
| 2012 | $25.2M |
| 2013 | $17.9M |
| 2014 | $10.2M |
| 2015 | $10.6M |
| 2016 | $3.2M |
| 2017 | $10.7M |
| 2018 | $10.3M |
| 2019 | $5.8M |
| 2020 | $8.2M |
| 2021 | $4.4M |
| 2022 | -$68,000 |
| 2023 | $426,000 |
| 2024 | $20,000 |
How accurately did Altimmune's revenue projections match actual performance?
Altimmune saw the greatest revenue growth in 2017, when revenue increased by 231.82%.
Altimmune had the lowest revenue growth in 2022, when revenue changed by -101.54%.
| Year | Altimmune growth |
|---|---|
| 2011 | 16%↑ |
| 2012 | 4%↑ |
| 2013 | -29%↓ |
| 2014 | -43%↓ |
| 2015 | 4%↑ |
| 2016 | -70%↓ |
| 2017 | 232%↑ |
| 2018 | -4%↓ |
| 2019 | -44%↓ |
| 2020 | 41%↑ |
| 2021 | -46%↓ |
| 2022 | -102%↓ |
| 2023 | -726%↓ |
| 2024 | -95%↓ |
Do you work at Altimmune?
Did Altimmune meet its revenue projections?
| CEO | Vipin K. Garg Ph.d |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 27 |
| Date Founded | 1997 |
| Headquarters | Gaithersburg, Maryland |
| Number of Locations | 1 |
| Revenue | $20,000 |
| Net Income | -$84,713,000 |
| EBITDA | ($3.2M) (2015) |
| PE Ratio | -0.31 |
| Tax Rate | 0.0% |
| Market Capitalization | $29.2M |
| Total Assets | $206,928,000 |
| Ticker | ALT |
Altimmune received early financing of $16.0M on 2015-02-17.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $16M | 02/2015 |
| Post Ipo Equity | $14.7M | 08/2017 |
| Post Ipo Equity | $17M | 09/2018 |
| Grant | $3.7M | 08/2019 |
| Investors | Security type |
|---|---|
| Novartis Venture Fund | Post Ipo Equity |
| HealthCap | Post Ipo Equity |
| TRUFFLE CAPITAL | Post Ipo Equity |
| Redmont Capital | Post Ipo Equity |
| Biomedical Advanced Research and Development Authority (BARDA) | Grant |
Zippia gives an in-depth look into the details of Altimmune, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Altimmune. The employee data is based on information from people who have self-reported their past or current employments at Altimmune. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Altimmune. The data presented on this page does not represent the view of Altimmune and its employees or that of Zippia.
Altimmune may also be known as or be related to ALTIMMUNE INC., Altimmune, Altimmune Inc and Altimmune, Inc.